Cancer Research forms an innate part of CPAA with the major objective comprising translational community-based research projects. The analysis is validated and disseminated through publications in peer-reviewed national and international journals, presentations in conferences and communicating the key messages to the community. The focus of the Research team is translational research in the realm of identification of ‘Predictive Markers’ in Oral Cancer’ and ‘Cervical Cancer’, the Research Team also focuses on detection of viral strain through modern molecular techniques, which does the analysis based on both phenotype and genotype. and study the psychosocial effects of cancer on patients and family members.
CPAA is uniquely positioned to understand the psychological issues that arise when a family member is diagnosed with cancer. We conduct research on appropriate topics affecting patients, parents, children and siblings. Translational research is conducted on the genetic profile of an individual susceptible to cancer or protects them against cancer in the face of faulty risk enhancing habits.
CPAA conducts systematic scientific studies of cancer-related issues, such as risk factors, epidemiology and psychosocial effects on patients with cancer and their loved ones including caregivers. The studies are conducted after prior ethical approval is granted from the relevant Institutional Ethics Committees. In continuation of its preventive approach, and complementing its research and early detection initiatives, CPAA’s mission is to protect underprivileged girls from the risk of cervical cancer by providing free HPV vaccines, thereby safeguarding their future and empowering them to live free from the burden of this disease.
A. Translational Research Studies:
Project 1: “Molecular Characterization of HPV testing Using Hybrid Capture: Integrating Phenotypic and Genotypic Analysis”
Human Papillomavirus (HPV) is the leading cause of cervical cancer, which continues to disproportionately affect women from underprivileged communities due to limited access to preventive healthcare and screening services. This project aims to bridge the gap between cutting-edge molecular research and community outreach by implementing Hybrid Capture technology for HPV testing.
Through this initiative, CPAA will conduct community-based cervical cancer screening programs, focusing on underprivileged and at-risk women. Samples collected will undergo Hybrid Capture analysis, enabling both phenotypic and genotypic characterization of HPV strains. This dual approach will provide critical insights into the prevalence of high-risk HPV genotypes in the community, their correlation with clinical outcomes, and potential protective or susceptibility markers.
The project further integrates awareness and education campaigns to empower women with knowledge about cervical cancer prevention, HPV vaccination, and the importance of regular screening. Results from the molecular analysis will not only guide individual-level preventive measures but also contribute to population-level data, strengthening public health strategies and scientific understanding of HPV-related cancer risks in India.
Ultimately, this project seeks to create a sustainable model of translational research, where laboratory innovations like Hybrid Capture are directly applied to community outreach programs, ensuring that the benefits of advanced molecular diagnostics reach the most vulnerable populations.
Project 2: “Eliminating Cervical Cancer through Free HPV Vaccination”
Vaccination is recognized as the most effective preventive measure against cervical cancer. However, accessibility to vaccines and awareness about their importance remain critically low among socio-economically disadvantaged groups.
The project “Eliminating Cervical Cancer through Free HPV Vaccination” aims to bridge this gap by providing free HPV vaccines to underprivileged girls, thereby safeguarding their health and ensuring a future free from the burden of cervical cancer. Alongside vaccination, the initiative will incorporate community-based education and awareness programs, engaging girls, parents, and caregivers to emphasize the significance of prevention and long-term protection.
In partnership with schools, NGOs, and healthcare providers, the project will conduct vaccination camps in underserved communities, while also implementing systematic monitoring and evaluation to track coverage and impact. By combining access to life-saving vaccines with community empowerment, this initiative directly supports both national and global goals to eliminate cervical cancer as a public health concern, while addressing health inequities and protecting future generations.
Project 3: Standardized Approaches to HPV Vaccination and HPV DNA Screening for Cervical Cancer Prevention and Biomarker Identification
This seeks to develop optimized, evidence-based approaches for HPV vaccination and DNA testing. Leveraging Hybrid Capture molecular technology, the study will establish sensitive and reproducible methods for genotype detection while designing scalable vaccination models tailored to underserved populations.
By uniting scientific rigor with community-based implementation, the initiative will ensure ethical oversight, systematic monitoring, and measurable outcomes. Integrating vaccination and molecular screening into a single early detection framework, the project aims to lower cervical cancer incidence and mortality, especially among vulnerable groups. The outcomes will provide a replicable model for large-scale prevention, advancing both national and global goals of eliminating cervical cancer as a public health priority.
Psychosocial Projects: To Study the Psychosocial Effect of Cancer On Patients And Family Members
B. RESEARCH PUBLICATIONS: (2012 – 2022)
Clinical Implications of Single Nucleotide Polymorphisms in Oral Cancer
2022: Hetal Damani Shah and Dhananjaya Saranath
Modern Research Dentistry, Published: June 03, 2022 Volume 7 – Issue 2
Oral cancer is a high incidence cancer with well-established risk factors including tobacco, alcohol, areca nut, and HR-HPV 16/18. Additional risk factors such as Single Nucleotide Polymorphisms (SNPs) associated with genetic susceptibility, disease progression and prognosis. A comprehensive review of clinically relevant SNPs is synopsized in the current article.
Cervical Cancer in India: Prevention and Control
2022: Dr. Dhananjaya Saranath
SCRIBE, Annual Science Journal, Sophia College (Autonomous), Mumbai | Volume 3, 2022
Cervical cancer ranks as the second most common cancer in females in India with 123,992 new cases annually, and 77,348 deaths (25% of global burden). Every 7-8 minute a woman in India dies due to the cancer. Cervical Cancer is caused by High-Risk Human Papilloma Virus (HR-HPV) and is preventable by simple means of HPV vaccination.
Perceived Risk, Anxiety and Alexithymia in Sisters of Breast Cancer Patients
2018: Veena Mishra and Dhananjaya Saranath
Journal Womens Health, Issues7 Care 2018, 7:2. DOI: 10.4172/2325-9795.1000303
High-Risk Human Papillomavirus in Oral Cancer: Clinical Implications.
Subuhi Yete, Wendy D’Souza, Dhananjaya Saranath Oncology, 94(3), 133 – 141, 2018.
Whole genome expression profile in chewing-tobacco-associated oral cancers: a pilot study. Medical Oncology
2015: Sanjukta Chakrabarti, Shaleen Multani, Jyoti Dabholkar, Dhananjaya Saranath
doi: 10.1007/s12032-015-0483-4 , 32:60-71, 2015.
Editorial: Current status of cancer burden : Global and Indian Scenario
2014: Dhananjaya Saranath and Aparna Khanna | Biomedical Research Journal, 1 (1), 2014.
Biomedical Research Journal
2014: Editors–in-Chief: Dr. Dhananjaya Saranath & Dr. Aparna Khanna
April Issue Volume 1, Issue 1, pp1-85, 2014.
Perception of young adults toward hookah use in Mumbai
Karnik Dani K, Oswal K, Maudgal S, Saranath D Indian Journal Cancer 2013
Assessing long-term motivation of trained volunteers of a psycho-oncology workshop.
2013: Asawari Gupta, Dhananjaya Saranath The National Medical J India, 26(3) 184-185, 2013
Genome-wide disease association study in chewing tobacco associated oral cancers
2012: Renu Bhatnagar, Jyoti Dabholkar, Dhananjaya Saranath
Oral Oncology, 2012, 48 (9): 831-835, 2012 | DOI information: 10.1016/j.oraloncology.2012.03.007
C. ABSTRACTS AND POSTER PRESENTATIONS:
Association between demographic features and perceived social support in the mental adjustment to breast cancer.
Dr. Veena Shukla Mishra, Dr. Dhananjaya Saranath. Psycho-oncology, 28(3), 629-634, 2019
Assessment of coping in hematological childhood cancer patients.
Mallika Narayan , Veena Shukla Mishra, Dhananjaya Saranath.
Presented at in 2019 Kochi conference on Palliative care | Paper Awarded 2nd Prize.
Understanding the Experiences of Breast Cancer Patients in Seoul, South Korea-Patient Reported Outcome Study
Maudgal S, Han W | 44th Annual Meeting of Korean Cancer Association and 4th International Cancer Conference, Seoul-21st – 22nd June, 2018
Alexithymia in Breast Cancer Patients and Their Sisters in Seoul
Maudgal S, Han W, e-Poster presentation | UICC World Cancer Congress, Kuala Lumpur-1st-4th October, 2018
Patient Engagement for Metastatic Breast Cancer Patients-Whats App Counseling
Maudgal S, e-Poster presentation | UICC World Cancer Congress, Kuala Lumpur-1st-4th October, 2018
Perceived risk, anxiety and Alexithymia in sisters of breast cancer patients.
Dr. Veena Shukla Mishra and Dr. Dhananjaya Saranath. Presented at UICC 2018 conference, Kuala Lampur, Malaysia.
Assessing the quality of life among caregivers of patients with hematological cancer.
Dr. Veena Shukla Mishra and Dr. Dhananjaya Saranath. Presented at UICC 2018 conference, Kuala Lampur, Malaysia. 16 participant
Challenges in India About Breast Cancer and Breast Reconstruction: Methil B, Maudgal S, CANREHAB 2017 | Tata Memorial Hospital, Mumbai-7th-9th April, 2017
Knowledge and attitude towards cervical cancer screening among women in Mumbai, India.
Ms. Masara Shameem, Dr. Veena Shukla Mishra and Dr. Dhananjaya Saranath (Study Completed), 2014
Alexithymia in children with cancer and their siblings
Veena Shukla Mishra, Shubha Maudgal, Stephanie C.P.M. Theunissen, Carolien Rieffe
Journal of Psychosomatic Research, 72 , 266–268, 2012
D. Communicating Paper’s:
Diagnostic and Prognostic Biomarkers in cervical cancer: A comprehensive review, communicated paper- Prasad.P (Priya Prasad) & Khare.N (Dr. Noopur Khare) (2025)
Precision in prevention: Optimizing HPV Screening Systems, communicated paper- Lawrence.R (Rochelle Lawrence) & Khare.N (Dr. Noopur Khare) (2025)
E. LIST OF PUBLICATIONS IN THE FIELD OF CANCER